Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of teriflunomide added to glatiramer acetate in multiple sclerosis
2006-004893-29Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of teriflunomide in multiple sclerosis (MS) (3 arms), sponsored by Sanofi. Primary endpoint: Safety and tolerability. Started Dec 2006; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2006-004893-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004893-29.